Daily Brief Archive: July 10, 2026 — U.S. & Hong Kong Stock Analysis
Free previewU.S. Markets
- S&P +0.8%, Nasdaq +1.3% — chips led the tape right through the Iran escalation
- SMH +2.5% with MU +4.5%, AMD +5.7%, SNDK +7.6%; falling crude defused the inflation alarm
- SK Hynix's IPO was 7x oversubscribed at $149; it debuts on Nasdaq today as SKHY
- IONS -24% on the failed AstraZeneca-partnered ATTR-CM Phase 3; BBIO +15% as the rival winner
- COST -4.2%: June comps of +8.8% missed, and a 42x multiple has no room for 'merely in line'
Hong Kong
- HSI +0.57% in a structural tape: property, materials and brokers strong, big tech soft
- The memory chain surged into the SKHY debut — GigaDevice ripped 22% in a day
- WuXi Biologics +5.6%: UBS lifted its target to HK$51.10 amid buybacks and upbeat CRO pre-announcements
- MiniMax slid another 7.5% into oversold territory — unlock supply still hasn't cleared
- Alibaba extended gains at the highs as the China AI re-rating entered day three
Today's Watchlist
- SKHY's debut is the memory sector's pricing ceremony — Micron's direct comp has arrived
- Today's action: re-opened the RIVN long (offering overhang cleared); all other 46 positions held
- Delta reports premarket today — summer fares are the consumer thermometer
- Earnings season nears: SYF 7/21, TSLA 7/22 — volatility ratchets up from here
- The Iran conflict is escalating yet markets are desensitizing — falling crude is the macro signal that matters
Deep Dives (0 names)
No deep-dive names match the current filters
Rapid Scan (5 names)
| Ticker | Close | Change | Score | Direction | One-line take |
|---|---|---|---|---|---|
 RXTUS | $4.37 | -33.59% | 4 | Neutral | Down 33.6% in a single-day evisceration erasing the month's gains; the +345% YTD rollercoaster is mid-plunge — stand clear |
 FBRXUS | $36.7 | +78.33% | 5 | Neutral | Up 78.3% on 7.5x volume — a micro-cap biotech detonation whose flip side is an equally fast zero; look, don't touch |
 TRAXUS | $32.4 | +55.99% | 4 | Neutral | Up 56% in a +74% week for the freshly listed biotech — no history, no averages, pure roulette |
 ESPRUS | $3.19 | +0.00% | 4 | Neutral | Flat but on 4.5x volume a third day — money is quietly cycling through the micro-cap pharma, direction undeclared |
 MSEXUS | $54.53 | -0.57% | 4 | Neutral | Down 0.6% on 4.3x volume for the small water utility; newsless volume gets filed as noise |